316 related articles for article (PubMed ID: 24075993)
1. The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells.
Wu Y; Wang Y; Yang XH; Kang T; Zhao Y; Wang C; Evers BM; Zhou BP
Cell Rep; 2013 Oct; 5(1):224-36. PubMed ID: 24075993
[TBL] [Abstract][Full Text] [Related]
2. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y
Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032
[TBL] [Abstract][Full Text] [Related]
3. FBXO24 Suppresses Breast Cancer Tumorigenesis by Targeting LSD1 for Ubiquitination.
Dong B; Song X; Wang X; Dai T; Wang J; Yu Z; Deng J; Evers BM; Wu Y
Mol Cancer Res; 2023 Dec; 21(12):1303-1316. PubMed ID: 37540490
[TBL] [Abstract][Full Text] [Related]
4. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
Sci Rep; 2018 Jan; 8(1):73. PubMed ID: 29311580
[TBL] [Abstract][Full Text] [Related]
5. LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem-like Cells.
Liu C; Liu L; Chen X; Cheng J; Zhang H; Zhang C; Shan J; Shen J; Qian C
Cancer Res; 2018 Feb; 78(4):938-949. PubMed ID: 29259010
[TBL] [Abstract][Full Text] [Related]
6. The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer.
Diefenbacher ME; Popov N; Blake SM; Schülein-Völk C; Nye E; Spencer-Dene B; Jaenicke LA; Eilers M; Behrens A
J Clin Invest; 2014 Aug; 124(8):3407-18. PubMed ID: 24960159
[TBL] [Abstract][Full Text] [Related]
7. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y
Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255
[TBL] [Abstract][Full Text] [Related]
8. Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer.
Liu J; Feng J; Li L; Lin L; Ji J; Lin C; Liu L; Zhang N; Duan D; Li Z; Huang B; Zhang Y; Lu J
EMBO Rep; 2020 Feb; 21(2):e48597. PubMed ID: 31833203
[TBL] [Abstract][Full Text] [Related]
9. The histone demethylase LSD1 is required for estrogen-dependent S100A7 gene expression in human breast cancer cells.
Yu SE; Jang YK
Biochem Biophys Res Commun; 2012 Oct; 427(2):336-42. PubMed ID: 23000163
[TBL] [Abstract][Full Text] [Related]
10. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology.
Lim S; Janzer A; Becker A; Zimmer A; Schüle R; Buettner R; Kirfel J
Carcinogenesis; 2010 Mar; 31(3):512-20. PubMed ID: 20042638
[TBL] [Abstract][Full Text] [Related]
11. ERRα protein is stabilized by LSD1 in a demethylation-independent manner.
Carnesecchi J; Cerutti C; Vanacker JM; Forcet C
PLoS One; 2017; 12(11):e0188871. PubMed ID: 29190800
[TBL] [Abstract][Full Text] [Related]
12. USP28 regulates deubiquitination of histone H2A and cell proliferation.
Li F; Han H; Sun Q; Liu K; Lin N; Xu C; Zhao Z; Zhao W
Exp Cell Res; 2019 Jun; 379(1):11-18. PubMed ID: 30910399
[TBL] [Abstract][Full Text] [Related]
13. LSD1 demethylates HIF1α to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis.
Lee JY; Park JH; Choi HJ; Won HY; Joo HS; Shin DH; Park MK; Han B; Kim KP; Lee TJ; Croce CM; Kong G
Oncogene; 2017 Sep; 36(39):5512-5521. PubMed ID: 28534506
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis.
Wang Q; Ma S; Song N; Li X; Liu L; Yang S; Ding X; Shan L; Zhou X; Su D; Wang Y; Zhang Q; Liu X; Yu N; Zhang K; Shang Y; Yao Z; Shi L
J Clin Invest; 2016 Jun; 126(6):2205-20. PubMed ID: 27183383
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
Vasilatos SN; Katz TA; Oesterreich S; Wan Y; Davidson NE; Huang Y
Carcinogenesis; 2013 Jun; 34(6):1196-207. PubMed ID: 23354309
[TBL] [Abstract][Full Text] [Related]
16. Oct4-Mediated Inhibition of Lsd1 Activity Promotes the Active and Primed State of Pluripotency Enhancers.
AlAbdi L; Saha D; He M; Dar MS; Utturkar SM; Sudyanti PA; McCune S; Spears BH; Breedlove JA; Lanman NA; Gowher H
Cell Rep; 2020 Feb; 30(5):1478-1490.e6. PubMed ID: 32023463
[TBL] [Abstract][Full Text] [Related]
17. USP28 and USP25 are downregulated by Vismodegib in vitro and in colorectal cancer cell lines.
Wang H; Meng Q; Ding Y; Xiong M; Zhu M; Yang Y; Su H; Gu L; Xu Y; Shi L; Zhou H; Zhang N
FEBS J; 2021 Feb; 288(4):1325-1342. PubMed ID: 32578360
[TBL] [Abstract][Full Text] [Related]
18. The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes.
Cuyàs E; Gumuzio J; Verdura S; Brunet J; Bosch-Barrera J; Martin-Castillo B; Alarcón T; Encinar JA; Martin ÁG; Menendez JA
Aging (Albany NY); 2020 Mar; 12(6):4794-4814. PubMed ID: 32191225
[TBL] [Abstract][Full Text] [Related]
19. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.
Qin J; Zhou Z; Chen W; Wang C; Zhang H; Ge G; Shao M; You D; Fan Z; Xia H; Liu R; Chen C
Nat Commun; 2015 Sep; 6():8471. PubMed ID: 26419610
[TBL] [Abstract][Full Text] [Related]
20. LSD1 overexpression is associated with poor prognosis in basal-like breast cancer, and sensitivity to PARP inhibition.
Nagasawa S; Sedukhina AS; Nakagawa Y; Maeda I; Kubota M; Ohnuma S; Tsugawa K; Ohta T; Roche-Molina M; Bernal JA; Narváez AJ; Jeyasekharan AD; Sato K
PLoS One; 2015; 10(2):e0118002. PubMed ID: 25679396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
